NovaTract Surgical develops laparoscopic medical devices aimed at reducing the number of incisions required for minimally invasive surgery. Its initial product is designed specifically to address that need. The company licensed its core technology from Yale University. It is led by CEO Eleanor Tandler and is based in New Haven, Conn. NovaTract raised $2.37M in a Series A to advance commercialization and bring its first product to market by mid-2013. Connecticut Innovations and other investors have supported the company through earlier pre-seed and seed investments. NovaTract Surgical is developing laparoscopic medical devices intended to reduce the number of incisions used in minimally invasive abdominal surgery. The company is initially focusing on an internal organ retraction device to aid procedures such as gall bladder removals and appendectomies. The device is intended to make single-port and natural orifice transluminal endoscopic surgery methods easier for general surgeons. NovaTract licensed its core technology from Yale University; the technology and techniques were developed by scientific founder Kurt E. Roberts, M.D. The company is led by co-founder and CEO Eleanor Tandler. Financially, NovaTract has been raising seed-stage funding, including a recent $500K round and a prior $150K raise earlier in 2011. NovaTract Surgical, LLC is a New Haven, CT–based developer of specialized surgical tools for single-port laparoscopic and natural orifice transluminal endoscopic surgery. Its tools are designed to reduce postoperative pain, shorten recovery times, lower the risk of complications, and improve cosmetic outcomes. The company’s technology is licensed from Yale University. NovaTract has raised $150K in pre-seed funding and intends to use the capital to complete the design of its tools. Investors in the round include Advantage Capital Partners and Ironwood Capital. CEO Eleanor Tandler said the funding will allow NovaTract to continue to grow the business and create jobs in Connecticut.

Total raised

$3M

Funding rounds

3

Latest round

Series A

Latest activity

Jun 2012